In the preceding decade, AP hospitalizations increased, but associated mortality declined. Associated CP has emerged as a leading contributor for AP-related hospitalizations. Further research is needed to identify novel interventions to prevent disease progression of AP.
A cute pancreatitis (AP) is the single most common specific gastrointestinal diagnosis for inpatient hospitalization, and inpatient costs reach an estimated $2.6 billion annually. 1 The most common risk factors associated with AP are gallstones and alcohol. 2 Overall, AP is associated with a significant mortality rate of 1% to 5%, which has improved from historical data.
Over the last few decades, the incidence of AP in Western countries has steadily increased. 3 Emergency department (ED) visits and hospitalizations for pancreatitis have also shown a steady rise paralleling the increase in incidence outlined above. 4 Multiple hypotheses have been generated to explain the increased incidence of AP. Although alcohol consumption may explain the trends in some countries, alcohol consumption has decreased in the United States. 5, 6 In addition, prevalence of cigarette smoking across the United States has declined between 1996 and 2012 (median, 0.75%/year). 7 It is presumed that gallstone-related disorders are a more probable cause of AP in the United States given the rise in obesity and an increasingly aging population. 8 Another major contributor for increasing detection and diagnosis of AP is more frequent laboratory testing. 9 With implementation of the Affordable Care Act, the emphasis is to provide high-value care; therefore, prevention of readmissions is one vital measure to reduce AP-related hospitalizations and inappropriate health care resource utilization.
There is a lack of large population-based studies from the United States that have evaluated the role of different etiologies in explaining the increasing prevalence of AP-related hospital admissions. To further investigate this issue, we analyzed the Nationwide Inpatient Sample (NIS), the largest inpatient database in the United States. Our aim was to elucidate the influence of changes in AP-related etiologies and evaluate clinically relevant hospitalbased outcomes.
MATERIALS AND METHODS

Data Source
The NIS Healthcare Cost Utilization Project (HCUP), an administrative claims databank, is a data compilation of more than 8 million inpatient admissions per year from approximately 1000 hospitals (representing about 85% of all nonfederal hospitals). It is designed to approximate a 20% stratified probability sample of patients from all nonfederal acute care hospitals in the United States. Discharge weights are provided, which allows extraction of nation-level estimates from the unweighted database information. The NIS-HCUP database was queried from 2002 to 2012 using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis and procedure codes. Hospitalizations for AP were selected using the ICD-9-CM diagnostic code 577.1 as primary discharge diagnosis. Related etiologies and associated diagnoses were queried from secondary diagnoses using respective ICD-9-CM codes Supplemental Table 1 , http://links.lww.com/MPA/A566). The following exclusions were applied: (a) age 17 years or less; (b) patients transferred from an outside hospital (because the duration and complications of prior hospitalization are not known); and (c) all codes describing status of pregnancy.
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The Ohio State University Data and Specimen Policy and Human Subjects Research Policy do not require institutional review board approval for a population-based public data set.
Patients and Outcomes
Patient-level variables included age, sex, race, median household income for patient's zip code (quartiles), and insurance status. Race/ethnicity was categorized as white, black, Hispanic, and others. Insurance status was categorized as Medicare, Medicaid, private insurance, and uninsured/other based on the primary payer listed on the discharge record. Hospital location and teaching status were combined into a single variable with the following categories: rural, urban nonteaching, and urban teaching hospital. Hospital bed size was classified as small, medium, or large based on an algorithm developed by HCUP. Hospital region was classified by the US Census Bureau as Northeast, Midwest, South, or West.
The following etiologies were evaluated in association with a primary diagnosis of AP: gallstone-related disorders, alcoholrelated disorders, pancreatic neoplasm, current and prior history of smoking tobacco, chronic pancreatitis (CP), and pancreatic anomalies (including pancreatic divisum). The following diseases were evaluated for associations with a primary diagnosis of AP: hyperlipidemia, obesity (including morbid obesity), cholangitis, acute cholecystitis, diabetes mellitus, nonalcoholic fatty liver disease, and metabolic syndrome. According to guidelines from the National Heart, Lung, and Blood Institute and the American Heart Association, metabolic syndrome is diagnosed when a patient has at least 3 of the following 5 conditions: diabetes, hypertension, hypertriglyceridemia, low high-density lipoprotein cholesterol, and abdominal obesity. 11 Because NIS diagnoses are based on ICD-9-CM coding (lack of specific code for low high-density lipoprotein cholesterol) and in an attempt to be more specific, we defined presence of metabolic syndrome when hyperlipidemia, hypertension, obesity, and diabetes were all identified in a given patient admission.
The presence of a primary diagnosis of AP, related etiologies and disease conditions, and clinical outcomes were compared between 2 periods. A span of 4 years between 2009 and 2012 was compared with an equivalent span between 2002 and 2005. We allocated adequate time span between the study period to provide sufficient contrast and to prevent overlap of events.
The primary outcome of interest was the frequency of AP-related hospital admissions and distribution of etiologies and disease associations. Additional outcomes evaluated include the effect of period on AP-related mortality rate, length of hospital stay, and total hospitalization costs and charges. The duration of hospital stay and incurred costs were collectively referred to as health care resource utilization. The amount a facility bills for a patient's care refers to the hospital charge. In contrast, hospital cost is the amount collected by a health care facility for each service and is usually less than the amount billed. To adjust for inflation, the total charges and costs were corrected to the 2012 value using the United States Bureau of Labor Statistics Consumer Price Index Inflation Calculator (http://www.bls.gov/data/inflation_calcu-lator.htm).
Statistical Analysis
The study schema is detailed in Figure 1 . Categorical variables were tested for statistical significance with w 2 analysis. Continuous variables were tested using the Student's t-test. The mean and standard error were calculated for all continuous outcomes, and frequency counts and percentages for categorical outcomes. Statistical significance was defined by P <0.05. Multivariate logistic regression models were fit for each dichotomous outcome, and multivariate linear regression models were fit if the outcome variables were continuous.
Univariate analysis was performed to compare demographic characteristics, hospital features, etiologies, associated diseases, and outcomes of AP between the 2 periods (2002-2005 vs 2009-2012). Subsequently, multivariate analyses for outcomes of mortality, length of stay, and hospital costs and charges were performed. This model was adjusted for "period," patient and hospital demographics, etiologies, and disease associations. Results from regression models were represented using an odds ratio (OR) or coefficient, as appropriate, and 95% confidence interval (CI); all regression models were performed separately.
For analysis of predictors of changes in trends of AP-related hospital admissions, all inpatient admissions (2002-2005 and 2009-2012) for any reason were included for analysis (n = 168,474,753). A logistic regression model was fit for a primary diagnosis of AP. The model contained patient and hospital demographics in addition to variables for period, etiologies (gallstone-related disorders, alcohol-related disorders, pancreatic neoplasm, CP, and tobacco use), and associations (hyperlipidemia, morbid obesity, and diabetes). Interactions between each etiology and/or association and period were evaluated. The odds of outcome of AP for those with the period interaction were interpreted separately. Based on the results of the multivariate These analyses were performed on weighted data from the NIS database using SAS 9.3 (SAS Institute, Cary, NC) using appropriate survey procedures to produce national estimates. Aside from race (18.6%) and income (2.5%), there were minimal missing data for all study subjects (Supplemental Table 2 , http:// links.lww.com/MPA/A566). Multiple states do not document race in the discharge information, so this observation is expected. The large population database facilitated exclusion of these missing data, and multiple imputation was not performed because missing data were assumed to be random.
RESULTS
Temporal Trends in the Prevalence of AP-Related Admissions
There was an increasing trend (P < 0.001) for AP-related hospital admissions from 2002 to 2012 ( Univariate comparison of demographic and hospital factors between the two periods (Table 1) demonstrated that patients were younger, frequently men, belonging to lower income groups, and more frequently admitted to urban teaching hospitals. Comparison of AP-related etiologies and associated diseases between the periods revealed that there was a marginal, albeit significant, decrease in prevalence of gallstone-related disorders. In contrast, there was an increase in prevalence of all the other etiologies and associated diseases. Notably, the greatest change was a more than 100% increase in prevalence of tobacco use and a 96% increase in prevalence of CP.
Analysis of AP-Related Outcomes
A 30% decrease in AP-related mortality was noted during the more recent period. Both unadjusted (OR, 0.62; 95% CI, 0.58-0.65; P < 0.001) and adjusted mortality rates (OR, 0.77; 95% CI, 0.72-0.83; P < 0.001) were lower in 2009-2012 when  compared with 2002-2005 (Table 2 ). Multivariate analysis also revealed a significant decrease in the length of hospital stay (−0.78 days; 95% CI, −0.85 to −0.70; P < 0.001) ( Table 2) . After controlling for inflation and adjusting for covariates, an increase in total hospital charges ($5109; 95% CI, $3976-$6243; P < 0.001) was observed. However, this did not translate to an increase in hospital costs. Adjusted analysis revealed a decrease in hospital costs by $573 per admission (95% CI, $−869 to $−277; P < 0.001). Other variables influencing the above outcomes are listed in Supplemental Tables 3, 4 , and 5, http://links.lww.com/ MPA/A566.
Multivariate Analysis of Prevalence Trends of AP Hospitalizations
A multivariate analysis model was constructed to analyze significant changes in trends of AP-related hospital admissions where the outcome was a primary discharge diagnosis of AP (Supplemental Tables 6, http://links.lww.com/MPA/A566). This revealed significant interactions between most AP-related conditions and period, with the exception of pancreatic neoplasms.
Comparison of the odds of primary diagnosis of AP between the two periods after adjusting for demographics, hospital factors, and AP-associated etiologies and conditions is shown in Table 3 . Although gallstone-related disorders contributed to the highest odds of AP in the former period (OR, 36.37; 95% CI, 35.32-37.46), the odds were decreased during the later period (OR, 29.85; 95% CI, 29.09-30.64). Meanwhile, the odds of CP have increased, and it has emerged as the condition with the highest odds of being associated with AP during the recent period (OR, 35.02; 95% CI, 33.94-36.14). Although associated with increasing trends of AP, there were modest decreases in the comparative odds of alcohol-related disorders, hyperlipidemia, and diabetes, whereas a minimal increase in associated tobacco use was observed. The presence of pancreatic neoplasm (OR, 1.46; 95% CI, 1.33-1.60) was not influenced by changing periods but was associated with an increase in prevalence of AP.
Acute Pancreatitis With Associated CP
Because CP was associated with the highest odds for a patient to be admitted with AP, we performed a subgroup analysis of this cohort to identify disease associations. There were a total of 246,577 patients discharged with a secondary diagnosis of CP. The prevalence rates of AP with associated CP more than (Fig. 2A) , whereas a marginal increase of prevalence rates was observed for AP patients without CP [213,394 (0.82%) to 226,670 (0.85%); P < 0.001]. Multivariate analysis (Table 4) for an outcome of AP with associated CP revealed that these patients were mostly men, belonging to the Black race, lower socioeconomic groups, with Medicaid or Medicare coverage, and mostly admitted to large-volume, teaching urban hospitals. Associated smoking, alcohol-related disorders, and pancreatic anomalies (predominantly pancreatic divisum) had the highest odds for predicting AP with associated CP.
Etiology-Associated Mortality Rates in AP
For all patients with a primary diagnosis of AP, all-cause inpatient mortality decreased [3749 (1.62%) to 2130 (0.79%); P < 0.001] (Fig. 2B) . Notably this trend was parallel to the decreased mortality seen in AP with associated CP (compared with those with AP but no underlying CP) [3631 (1.70%) to 2020 (0.89%); P < 0.001]. However, analysis of AP patients with a secondary diagnosis of CP, although decreasing [118 (0.65%) to 110 (0.26%); P < 0.001], had a significantly lower mortality rate (P < 0.001) for all the years from 2002 to 2012.
DISCUSSION
The prevalence of hospitalizations for AP has increased significantly in the United States from 2002 to 2012. Gallstonerelated disorders are a frequently associated etiology of AP, but with declining frequency. Despite an increasing prevalence of constituents of metabolic syndrome, these have modest influences on the increasing trend of AP-related hospitalizations. Rather, the increase in AP-related hospitalizations is largely due to concomitant increase in the prevalence of associated CP. Despite increasing AP-related hospital admissions, AP-associated mortality has further decreased over the last decade. Comparatively, the mortality rate in AP with associated CP is lower. These trends are important to identify opportunities to prevent hospitalizations related to AP and decrease avoidable utilization of health care resources.
Our analysis demonstrates a 16.4% increase in AP admissions from 2002 to 2012. Prior population-based studies have evidenced a similar increase in ED visits and hospital admissions for AP. 4, 12 Although the number of hospital admissions for AP increased from 101,000 in 1988 to a peak of 210,000 in 2002, 14 It is conceivable that the gamut of AP admissions is composed of many readmissions, especially given the natural history of specific subsets of AP patients. 15 A population-based study of over 7000 unique hospitalizations with AP found that over 20% were readmitted with another episode of AP. The model was adjusted for patient and hospital demographics, etiologies (gallstone-related disorders, alcohol-related disorders, pancreatic neoplasm, CP, and tobacco use), and AP associations (hyperlipidemia, morbid obesity, and diabetes).
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*Variables having significant interactions with period were analyzed separately.
The conventional belief is that increasing AP is related to the global epidemic of obesity, which in turn promotes gallstone formation and can result in biliary AP. 8, 17 In support of obesityrelated increase in new diagnosis of AP, our analysis revealed a more than threefold increase in associated prevalence of components of metabolic syndrome and morbid obesity. Although this may explain the escalation in index cases of AP, we found that increasing AP hospitalizations was most influenced by a near doubling of AP with associated CP and was not sufficiently supported by the rising prevalence of metabolic syndrome.
More importantly, the subgroup analysis of AP with associated CP identified a specific patient population. These patients had higher odds of tobacco use, alcohol-related disorders, Black race, and lower socioeconomic background and were mostly covered by Medicare/Medicaid. In addition, these patients sought care at large, urban teaching hospitals. Fortifying our findings, statewide data (from Maryland) have also demonstrated lower mortality rates and fewer complications such as multisystem organ failure, mechanical ventilation use, or intensive care unit management in this subgroup compared with AP patients without CP. 15 We also discovered an additional subset of patients with pancreatic anomalies (mostly pancreatic divisum), who had the highest odds of associated CP.
Although this study exhibited an increase in AP hospitalizations during the 10-year study period, there was a significant reduction in AP-related mortality rate and length of hospital stay. Other studies have also shown decreasing mortality rates over the last decade, which are further corroborated by our finding of a decrease from 3749 (1.62%) to 2130 (0.79%) during the study period. 12, 13, [18] [19] [20] These outcomes are justifiable because milder cases of AP are becoming easier to detect with better testing, and complications can be identified earlier in the disease course. Furthermore, recurrences after the first attack of AP tend to be milder in intensity with substantially lower mortality. 8 Although mortality is low, the disease-related morbidity and costs of AP with associated CP is substantial. Although accounting for only 14,195 discharges in 2010, CP resulted in a cost of $150 million, mostly due to readmissions for acute exacerbations of AP.
14 With an increasing population of AP with associated CP, these costs are expected to increase. Conceptually, although AP may progress to CP, these are distinct clinical entities with distinct histopathology and associated clinical outcomes. 15, 21 It is widely acknowledged that recurrent bouts of AP increase the likelihood of developing CP, and in a study that included only patients with a sentinel event of AP, specifically male sex, alcohol use, and severity of disease were predictive of readmission. 22 Thus, a concerted effort is needed prevent progression of AP to CP, which should include risk factor modification (treatment of tobacco and alcohol use disorders) and identification of novel therapeutic agents that prevent disease recurrence and progression.
There are several limitations to this study. First, as with all administrative databases, coding errors represent a potential limitation of the present study. However, previous investigations evaluating the validity of codes for AP and CP suggest they are fairly accurate. A systematic review from Europe showed an accuracy of 80.3% (median) for ICD-9-CM-based diagnostic coding for AP. 23 A study involving 3000 patients with a primary diagnosis of CP at single tertiary care hospital over 10 years (1998-2008) demonstrated a coding accuracy of 75%. 24 Another European study observed a minimal underestimation of the discharge coding for AP and CP by 15.8% and 6%, respectively. 25 Similar to these studies, a more recent evaluation of the ICD-9-CM diagnostic coding for AP in the United States reported a specificity of 85%. 26 Second, the patient's race is not systematically reported by multiple states, so a definitive conclusion about the influence of race is not *Estimates of national quartiles are subject to variations on an annual basis: low ($1-$38,999), moderate ($39,000-$47,999), high ($48,000-$62,999), and very high ($63,000 or more). † Bed size categories are based on hospital beds and are specific to the hospital's location and teaching status. Bed size assesses the number of short-term acute beds in a hospital.
NAFLD indicates nonalcoholic fatty liver disease.
possible. Third, the NIS database cannot account for unobserved characteristics that may influence an intervention, complication, or outcome, so inferring "causality" from observed associations is not valid. Although a global improvement in health care has most likely decreased AP-related mortality for all etiologies, the frequency of AP-related hospitalizations is increasing and CP represents the fastest growing associated health condition. Acute pancreatitis with associated CP presents some distinct features, including a specific subset of patients and relatively lower mortality rates while contributing to increasing health care resources. In contrast, AP not associated with CP demonstrates rather stable rates of hospitalization, despite the increasing prevalence of obesity and other components of metabolic syndrome. Thus, continued research addressing lifestyle factors and prevention of disease progression to CP are needed to further reduce the overall burden from AP-related hospitalizations.
